0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Brain Tumor Diagnosis and Therapeutics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-38G13549
Home | Market Reports | Health| Health Conditions| Cancer
Global Brain Tumor Diagnosis and Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Brain Tumor Diagnosis and Therapeutics Market Research Report 2024

Code: QYRE-Auto-38G13549
Report
January 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Brain Tumor Diagnosis and Therapeutics Market Size

The global Brain Tumor Diagnosis and Therapeutics market was valued at US$ 2581 million in 2023 and is anticipated to reach US$ 4685.7 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.

Brain Tumor Diagnosis and Therapeutics Market

Brain Tumor Diagnosis and Therapeutics Market

Brain tumors are treated with surgery, radiation therapy and chemotherapy. This report mainly focuses on brain tumor diagnosis and therapeutics market.
North American market for Brain Tumor Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Brain Tumor Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Brain Tumor Diagnosis and Therapeutics in Surgery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Brain Tumor Diagnosis and Therapeutics include GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co. and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Brain Tumor Diagnosis and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Tumor Diagnosis and Therapeutics.

Report Scope

The Brain Tumor Diagnosis and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Tumor Diagnosis and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Tumor Diagnosis and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Brain Tumor Diagnosis and Therapeutics Market Report

Report Metric Details
Report Name Brain Tumor Diagnosis and Therapeutics Market
Accounted market size in 2023 US$ 2581 million
Forecasted market size in 2030 US$ 4685.7 million
CAGR 9.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • MRI
  • CT Scan
  • Tissue Sampling
  • PET-CT Scan
  • Cerebral Arteriogram
  • Lumbar Puncture
  • Molecular Testing
  • EEG
Segment by Application
  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co., AstraZeneca, Bristol Myer Squibb, Novartis, Roche Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Brain Tumor Diagnosis and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Brain Tumor Diagnosis and Therapeutics Market growing?

Ans: The Brain Tumor Diagnosis and Therapeutics Market witnessing a CAGR of 9.8% during the forecast period 2024-2030.

What is the Brain Tumor Diagnosis and Therapeutics Market size in 2030?

Ans: The Brain Tumor Diagnosis and Therapeutics Market size in 2030 will be US$ 4685.7 million.

Who are the main players in the Brain Tumor Diagnosis and Therapeutics Market report?

Ans: The main players in the Brain Tumor Diagnosis and Therapeutics Market are GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co., AstraZeneca, Bristol Myer Squibb, Novartis, Roche Diagnostics

What are the Application segmentation covered in the Brain Tumor Diagnosis and Therapeutics Market report?

Ans: The Applications covered in the Brain Tumor Diagnosis and Therapeutics Market report are Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy

What are the Type segmentation covered in the Brain Tumor Diagnosis and Therapeutics Market report?

Ans: The Types covered in the Brain Tumor Diagnosis and Therapeutics Market report are MRI, CT Scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing, EEG

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 MRI
1.2.3 CT Scan
1.2.4 Tissue Sampling
1.2.5 PET-CT Scan
1.2.6 Cerebral Arteriogram
1.2.7 Lumbar Puncture
1.2.8 Molecular Testing
1.2.9 EEG
1.3 Market by Application
1.3.1 Global Brain Tumor Diagnosis and Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Surgery
1.3.3 Radiation Therapy
1.3.4 Chemotherapy
1.3.5 Immunotherapy
1.3.6 Targeted Therapy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Tumor Diagnosis and Therapeutics Market Perspective (2019-2030)
2.2 Brain Tumor Diagnosis and Therapeutics Growth Trends by Region
2.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Brain Tumor Diagnosis and Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Brain Tumor Diagnosis and Therapeutics Market Dynamics
2.3.1 Brain Tumor Diagnosis and Therapeutics Industry Trends
2.3.2 Brain Tumor Diagnosis and Therapeutics Market Drivers
2.3.3 Brain Tumor Diagnosis and Therapeutics Market Challenges
2.3.4 Brain Tumor Diagnosis and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue
3.1.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Tumor Diagnosis and Therapeutics Revenue
3.4 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio
3.4.1 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnosis and Therapeutics Revenue in 2023
3.5 Brain Tumor Diagnosis and Therapeutics Key Players Head office and Area Served
3.6 Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
3.7 Date of Enter into Brain Tumor Diagnosis and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Type
4.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2025-2030)
5 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Application
5.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
6.2 North America Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)
6.4 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
7.2 Europe Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)
7.4 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
9.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Introduction
11.1.4 GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Hitachi
11.2.1 Hitachi Company Detail
11.2.2 Hitachi Business Overview
11.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Introduction
11.2.4 Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.2.5 Hitachi Recent Development
11.3 Philips Healthcare
11.3.1 Philips Healthcare Company Detail
11.3.2 Philips Healthcare Business Overview
11.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Introduction
11.3.4 Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.3.5 Philips Healthcare Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Introduction
11.4.4 Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.4.5 Siemens Healthineers Recent Development
11.5 Toshiba Corporation
11.5.1 Toshiba Corporation Company Detail
11.5.2 Toshiba Corporation Business Overview
11.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Introduction
11.5.4 Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.5.5 Toshiba Corporation Recent Development
11.6 Fujifilm Corporation
11.6.1 Fujifilm Corporation Company Detail
11.6.2 Fujifilm Corporation Business Overview
11.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Introduction
11.6.4 Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.6.5 Fujifilm Corporation Recent Development
11.7 Shimadzu Corporation
11.7.1 Shimadzu Corporation Company Detail
11.7.2 Shimadzu Corporation Business Overview
11.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Introduction
11.7.4 Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.7.5 Shimadzu Corporation Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Detail
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Introduction
11.8.4 Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.8.5 Merck & Co. Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Introduction
11.9.4 AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.9.5 AstraZeneca Recent Development
11.10 Bristol Myer Squibb
11.10.1 Bristol Myer Squibb Company Detail
11.10.2 Bristol Myer Squibb Business Overview
11.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Introduction
11.10.4 Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.10.5 Bristol Myer Squibb Recent Development
11.11 Novartis
11.11.1 Novartis Company Detail
11.11.2 Novartis Business Overview
11.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Introduction
11.11.4 Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.11.5 Novartis Recent Development
11.12 Roche Diagnostics
11.12.1 Roche Diagnostics Company Detail
11.12.2 Roche Diagnostics Business Overview
11.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Introduction
11.12.4 Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
11.12.5 Roche Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of MRI
    Table 3. Key Players of CT Scan
    Table 4. Key Players of Tissue Sampling
    Table 5. Key Players of PET-CT Scan
    Table 6. Key Players of Cerebral Arteriogram
    Table 7. Key Players of Lumbar Puncture
    Table 8. Key Players of Molecular Testing
    Table 9. Key Players of EEG
    Table 10. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Brain Tumor Diagnosis and Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 12. Global Brain Tumor Diagnosis and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 13. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region (2019-2024)
    Table 14. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 15. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region (2025-2030)
    Table 16. Brain Tumor Diagnosis and Therapeutics Market Trends
    Table 17. Brain Tumor Diagnosis and Therapeutics Market Drivers
    Table 18. Brain Tumor Diagnosis and Therapeutics Market Challenges
    Table 19. Brain Tumor Diagnosis and Therapeutics Market Restraints
    Table 20. Global Brain Tumor Diagnosis and Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 21. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players (2019-2024)
    Table 22. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2023)
    Table 23. Ranking of Global Top Brain Tumor Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 24. Global 5 Largest Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
    Table 27. Date of Enter into Brain Tumor Diagnosis and Therapeutics Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 30. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2019-2024)
    Table 31. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 32. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2025-2030)
    Table 33. Global Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 34. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2019-2024)
    Table 35. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 36. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2025-2030)
    Table 37. North America Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 45. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 46. Latin America Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 50. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 51. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 52. GE Healthcare Company Detail
    Table 53. GE Healthcare Business Overview
    Table 54. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product
    Table 55. GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 56. GE Healthcare Recent Development
    Table 57. Hitachi Company Detail
    Table 58. Hitachi Business Overview
    Table 59. Hitachi Brain Tumor Diagnosis and Therapeutics Product
    Table 60. Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 61. Hitachi Recent Development
    Table 62. Philips Healthcare Company Detail
    Table 63. Philips Healthcare Business Overview
    Table 64. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product
    Table 65. Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 66. Philips Healthcare Recent Development
    Table 67. Siemens Healthineers Company Detail
    Table 68. Siemens Healthineers Business Overview
    Table 69. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product
    Table 70. Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 71. Siemens Healthineers Recent Development
    Table 72. Toshiba Corporation Company Detail
    Table 73. Toshiba Corporation Business Overview
    Table 74. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product
    Table 75. Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 76. Toshiba Corporation Recent Development
    Table 77. Fujifilm Corporation Company Detail
    Table 78. Fujifilm Corporation Business Overview
    Table 79. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product
    Table 80. Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 81. Fujifilm Corporation Recent Development
    Table 82. Shimadzu Corporation Company Detail
    Table 83. Shimadzu Corporation Business Overview
    Table 84. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product
    Table 85. Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 86. Shimadzu Corporation Recent Development
    Table 87. Merck & Co. Company Detail
    Table 88. Merck & Co. Business Overview
    Table 89. Merck & Co. Brain Tumor Diagnosis and Therapeutics Product
    Table 90. Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 91. Merck & Co. Recent Development
    Table 92. AstraZeneca Company Detail
    Table 93. AstraZeneca Business Overview
    Table 94. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product
    Table 95. AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 96. AstraZeneca Recent Development
    Table 97. Bristol Myer Squibb Company Detail
    Table 98. Bristol Myer Squibb Business Overview
    Table 99. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product
    Table 100. Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 101. Bristol Myer Squibb Recent Development
    Table 102. Novartis Company Detail
    Table 103. Novartis Business Overview
    Table 104. Novartis Brain Tumor Diagnosis and Therapeutics Product
    Table 105. Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 106. Novartis Recent Development
    Table 107. Roche Diagnostics Company Detail
    Table 108. Roche Diagnostics Business Overview
    Table 109. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product
    Table 110. Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)
    Table 111. Roche Diagnostics Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Brain Tumor Diagnosis and Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Brain Tumor Diagnosis and Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. MRI Features
    Figure 4. CT Scan Features
    Figure 5. Tissue Sampling Features
    Figure 6. PET-CT Scan Features
    Figure 7. Cerebral Arteriogram Features
    Figure 8. Lumbar Puncture Features
    Figure 9. Molecular Testing Features
    Figure 10. EEG Features
    Figure 11. Global Brain Tumor Diagnosis and Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 12. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application: 2023 VS 2030
    Figure 13. Surgery Case Studies
    Figure 14. Radiation Therapy Case Studies
    Figure 15. Chemotherapy Case Studies
    Figure 16. Immunotherapy Case Studies
    Figure 17. Targeted Therapy Case Studies
    Figure 18. Brain Tumor Diagnosis and Therapeutics Report Years Considered
    Figure 19. Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 20. Global Brain Tumor Diagnosis and Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 21. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region: 2023 VS 2030
    Figure 22. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players in 2023
    Figure 23. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2023)
    Figure 24. The Top 10 and 5 Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue in 2023
    Figure 25. North America Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. North America Brain Tumor Diagnosis and Therapeutics Market Share by Country (2019-2030)
    Figure 27. United States Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Europe Brain Tumor Diagnosis and Therapeutics Market Share by Country (2019-2030)
    Figure 31. Germany Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Share by Region (2019-2030)
    Figure 39. China Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Japan Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. India Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Australia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Latin America Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Country (2019-2030)
    Figure 47. Mexico Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Brazil Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Share by Country (2019-2030)
    Figure 51. Turkey Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. GE Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 54. Hitachi Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 55. Philips Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 56. Siemens Healthineers Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 57. Toshiba Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 58. Fujifilm Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 59. Shimadzu Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 60. Merck & Co. Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 61. AstraZeneca Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 62. Bristol Myer Squibb Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 63. Novartis Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 64. Roche Diagnostics Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Hurthle Cell Carcinoma Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35B1140
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Oncology Based Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6P7589
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global Internal Radiation Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17G14298
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global External beam Radiation Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5C14164
Thu Feb 08 00:00:00 UTC 2024

Add to Cart